 AFP |
FDA Approves Lucentis for Treatment of Diabetic Macular Edema; Mylan …
Proactive Investors USA & Canada Genentech, a member of the Roche Group (PINK:RHHBY), announced Lucentis (ranibizumab injection) was approved by the U.S. Food & Drug Administration for treatment of diabetic macular edema, an eye condition in people with diabetes that causes … FDA approves drug to treat diabetic macular edemaMedical Xpress FDA approves Lucentis (ranibizumab injection) for treatment of diabetic …Chem.Info Roche's Lucentis Wins Backing to Treat Diabetic BlindnessBloomberg Medical News Today –Counsel & Heal all 190 news articles » |
More details can be found at www.diabeteshowto.com
Discussion
Comments are disallowed for this post.
Comments are closed.